Pasar al contenido principal

NUEVOS ACTORES CON POTENCIAL PARA REGULAR LA DIFERENCIACION, ACTIVACION Y MIGRACION LINFOCITARIA EN EL MICROAMBIENTE TUMORAL

PID2020-116303RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The chemokine receptor CCR5 links memory CD4+ T cell metabolism to T Cell antigen receptor nanoclustering

  • Blanco, Raquel
  • Gómez de Cedrón, Marta
  • Gámez-Reche, Laura
  • Martín-Leal, Ana
  • González-Martín, Alicia
  • Lacalle, Rosa Ana
  • Ramirez, Ana
  • Mañes, Santos
© 2021 Blanco, Gómez de Cedrón, Gámez-Reche, Martín-Leal, González-Martín, Lacalle, Ramírez de Molina and Mañes., The inhibition of anabolic pathways, such as aerobic glycolysis, is a metabolic cornerstone of memory T cell differentiation and function. However, the signals that hamper these anabolic pathways are not completely known. Recent evidence pinpoints the chemokine receptor CCR5 as an important player in CD4+ T cell memory responses by regulating T cell antigen receptor (TCR) nanoclustering in an antigen-independent manner. This paper reports that CCR5 specifically restrains aerobic glycolysis in memory-like CD4+ T cells, but not in effector CD4+ T cells. CCR5-deficient memory CD4+ T cells thus show an abnormally high glycolytic/oxidative metabolism ratio. No CCR5-dependent change in glucose uptake nor in the expression of the main glucose transporters was detected in any of the examined cell types, although CCR5-deficient memory cells did show increased expression of the hexokinase 2 and pyruvate kinase M2 isoforms, plus the concomitant downregulation of Bcl-6, a transcriptional repressor of these key glycolytic enzymes. Further, the TCR nanoclustering defects observed in CCR5-deficient antigen-experienced CD4+ T cells were partially reversed by incubation with 2-deoxyglucose (2-DG), suggesting a link between inhibition of the glycolytic pathway and TCR nanoscopic organization. Indeed, the treatment of CCR5-deficient lymphoblasts with 2-DG enhanced IL-2 production after antigen re-stimulation. These results identify CCR5 as an important regulator of the metabolic fitness of memory CD4+ T cells, and reveal an unexpected link between T cell metabolism and TCR organization with potential influence on the response of memory T cells upon antigen re-encounter., This research was funded by the Spanish Ministerio de Economía y Competitividad (SAF2017–83732-R to SM), the projects PID2020-116303RB-I00/MCIN/AEI/10.13039/501100011033 (to SM) and PID2019-110183RB-C21/MCIN/AEI/10.13039/501100011033 (to AR), the Comunidad de Madrid (B2017/BMD-3733/IMMUNOTHERCAN-CM to SM; P2018/BAA-4343-ALIBIRD2020-CM to AR), and the Merck-Salud Foundation (to SM). AM-L was a recipient of the Formación del Personal Universitario predoctoral fellowship from the Spanish Ministry of Education (FPU13/04430)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults

  • Rojas, Itziar de
  • Barrio, Laura
  • Hernández, Isabel
  • Montrreal, Laura
  • García-González, Pablo
  • Marquié, Marta
  • Valero, Sergi
  • Cano, Amanda
  • Orellana, Adelina
  • Boada, Mercè
  • Mañes, Santos
  • Ruiz, Agustín
Cholesterol efflux capacity (CEC) is of interest given its potential relationship with several important clinical conditions including Alzheimer's disease. The inactivation of the APOE locus in mouse models supports the idea that it is involved in determining the CEC. With that in mind, we examine the impact of the plasma metabolome profile and the APOE genotype on the CEC in cognitively healthy elderly subjects. The study subjects were 144 unrelated healthy individuals. The plasma CEC was determined by exposing cultured mouse macrophages treated with BODIPY-cholesterol to human plasma. The metabolome profile was determined using NMR techniques. Multiple regression was performed to identify the most important predictors of CEC, as well as the NMR features most strongly associated with the APOE genotype. Plasma 3-hydroxybutyrate was the variable most strongly correlated with the CEC (r = 0.365; p = 7.3 × 10-6). Male sex was associated with a stronger CEC (r = -0.326, p = 6.8 × 10-5). Most of the NMR particles associated with the CEC did not correlate with the APOE genotype. The NMR metabolomics results confirmed the APOE genotype to have a huge effect on the concentration of plasma lipoprotein particles as well as those of other molecules including omega-3 fatty acids. In conclusion, the CEC of human plasma was associated with ketone body concentration, sex, and (to a lesser extent) the other features of the plasma lipoprotein profile. The APOE genotype exerted only a weak effect on the CEC via the modulation of the lipoprotein profile. The APOE locus was associated with omega-3 fatty acid levels independent of the plasma cholesterol level., A.R. and S.M. are funded by the Innovative Medicines Initiative 2 Joint Undertaking, which receives support from the European Union Horizon 2020 Research And Innovation Programme (ADAPTED grant no. 115975). S.M.’s research is also funded by the Spanish Ministry of Science and Innovation (PID2020-116303RB-I00/MCIN/AEI/10.13039/501100011033). A.R.’s research is also supported by Instituto de Salud Carlos III (ISCIII) via grants PI13/02434, PI16/01861, PI19/01301, and PI22/01403 Acción Estratégica en Salud, within the framework of the Spanish National R+D+I Plan and funded by the ISCIII-Subdirección General de Evaluación and the European Regional Development Fund (EDRF), as well as by the JPco-fuND-2 “Multinational Research Projects on Personalized Medicine for Neurodegenerative Diseases” PREADAPT project. I.d.R. is supported by a national grant from the Instituto de Salud Carlos III (ISCIII) FI20/00215. M.M. receives support from Instituto de Salud Carlos III (ISCIII) via grant PI19/00335 Acción Estratégica en Salud, within the framework of the Spanish National R+D+I Plan and funded by ISCIII-Subdirección General de Evaluación and the EDRF. AC acknowledges the support of the Instituto de Salud Carlos III (ISCIII) grant Sara Borrell (CD22/00125) and Ministerio de Ciencia e Innovación, Proyectos de Generación de Conocimiento grant PID2021-122473OA-I00. Fundacio ACE researchers research receives support from Grifols, Roche, Janssen, Life Molecular Imaging, Araclon Biotech, Alkahest, Laboratorio de Análisis Echevarne, and IrsiCaixa., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets

  • Paz-Cabezas, Mateo
  • Calvo-López, Tania
  • Romera-Lopez, Alejandro
  • Tabas-Madrid, Daniel
  • Ogando, Jesús
  • Fernández-Aceñero, María-Jesús
  • Sastre, Javier
  • Pascual-Montano, Alberto
  • Mañes, Santos
  • Díaz-Rubio, Eduardo
  • Pérez Villamil, Beatriz
Colorectal cancer consensus molecular subtypes (CMSs) are widely accepted and constitutes the basis for patient stratification to improve clinical practice. We aimed to find whether miRNAs could reproduce molecular subtypes, and to identify miRNA targets associated to the High-stroma/CMS4 subtype. The expression of 939 miRNAs was analyzed in tumors classified in CMS. TALASSO was used to find gene-miRNA interactions. A miR-mRNA regulatory network was constructed using Cytoscape. Candidate gene-miR interactions were validated in 293T cells. Hierarchical-Clustering identified three miRNA tumor subtypes (miR-LS; miR-MI; and miR-HS) which were significantly associated (p < 0.001) to the reported mRNA subtypes. miR-LS correlated with the low-stroma/CMS2; miR-MI with the mucinous-MSI/CMS1 and miR-HS with high-stroma/CMS4. MicroRNA tumor subtypes and association to CMSs were validated with TCGA datasets. TALASSO identified 1462 interactions (p < 0.05) out of 21,615 found between 176 miRs and 788 genes. Based on the regulatory network, 88 miR-mRNA interactions were selected as candidates. This network was functionally validated for the pair miR-30b/SLC6A6. We found that miR-30b overexpression silenced 3′-UTR-SLC6A6-driven luciferase expression in 293T-cells; mutation of the target sequence in the 3′-UTR-SLC6A6 prevented the miR-30b inhibitory effect. In conclusion CRC subtype classification using a miR-signature might facilitate a real-time analysis of the disease course and treatment response., This work was partially funded by: IMMUNOTHERCAN Comunidad de Madrid S2017/ BMD-3733; Fundacion Mutua Madrileña AP151962014; Bayer Healthcare BPV.M01BAY; Fundacion Rodriguez-Pascual EDRFERP.2013; Fundacion 2000 Merck-Serono F01MSER13. PID2020-116303RBI00/MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Superoxide Dismutase-3 Downregulates Laminin α5 Expression in Tumor Endothelial Cells via the Inhibition of Nuclear Factor Kappa B Signaling

  • Carmona-Rodríguez, Lorena
  • Martínez Rey, Diego
  • Martín-González, Paula
  • Franch, Mónica
  • Sorokin, Lydia
  • Mira, Emilia
  • Mañes, Santos
The balance between laminin isoforms containing the α5 or the α4 chain in the endothelial basement membrane determines the site of leukocyte diapedesis under inflammatory conditions. Extracellular superoxide dismutase (SOD3) induces laminin α4 expression in tumor blood vessels, which is associated with enhanced intratumor T cell infiltration in primary human cancers. We show now that SOD3 overexpression in neoplastic and endothelial cells (ECs) reduces laminin α5 in tumor blood vessels. SOD3 represses the laminin α5 gene (LAMA5), but LAMA5 expression is not changed in SOD1-overexpressing cells. Transcriptomic analyses revealed SOD3 overexpression to change the transcription of 1682 genes in ECs, with the canonical and non-canonical NF-κB pathways as the major SOD3 targets. Indeed, SOD3 reduced the transcription of well-known NF-κB target genes as well as NF-κB-driven promoter activity in ECs stimulated with tumor necrosis factor (TNF)-α, an NF-κB signaling inducer. SOD3 inhibited the phosphorylation and degradation of IκBα (nuclear factor of the kappa light polypeptide gene enhancer in B-cells inhibitor alpha), an NF-κB inhibitor. Finally, TNF-α was found to be a transcriptional activator of LAMA5 but not of LAMA4; LAMA5 induction was prevented by SOD3. In conclusion, SOD3 is a major regulator of laminin balance in the basement membrane of tumor ECs, with potential implications for immune cell infiltration into tumors., This research was funded by the Spanish Ministry of Economy and Competitiveness (SAF2017–83732-R), the Spanish Ministry of Science and Innovation (PID2020-116303RB-I00/MCIN/ AEI/10.13039/501100011033), the Comunidad de Madrid (B2017/BMD-3733; IMMUNOTHERCANCM), and the Asociación Española Contra el Cancer (AECC; PRYGN211240MAÑE). D.M.-R. was supported by a predoctoral fellowship from the Spanish Ministry of Science, Innovation and Universities and the EU European Social Fund (PRE2018-084023)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biomechanical properties of laminins and their impact on cancer progression

  • Nonnast, Elena
  • Mira, Emilia
  • Mañes, Santos
Laminins (LMs) constitute a family of heterotrimeric glycoproteins essential for the formation of basement membranes (BM). They act as molecular bridges between cells and the extracellular matrix (ECM), thereby transmitting signals influencing cell behavior and tissue organization. In the realm of cancer pathobiology, LMs regulate key processes such as migration, differentiation, or fibrosis. This review critically examines the multifaceted impact of LMs on tumor progression, with a particular focus on the isoform-specific structure-function relationships, and how this structural diversity contributes to the biomechanical properties of BMs. LM interactions with integrin and non-integrin cell surface receptors, as well as with other ECM proteins, modify the response of cancer cells to the ECM stiffness, ultimately influencing the capacity of malignant cells to breach the BM, a limiting step in metastatic dissemination. Comprehension of the mechanisms underlying LM-driven tumor biomechanics holds potential for better understand cancer pathobiology and design new targeted therapeutic strategies., Our research was funded by the Spanish Ministry of Science, Innovation and Universities (MCINU/AEI/10.13039/501100011033) grants PID2020-116303RB-I00 and PID2023-147125OB-I00, and the Asociación Española Contra el Cancer (AECC) Foundation (PRYGN211240MANE). EN was supported by a predoctoral fellowship from the Spanish Ministry of Science, Innovation and Universities and the EU European Social Fund (PRE2021-097603). SM belongs to the Spanish National Research Council (CSIC)’s Cancer Hub., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia

  • Morató, Xavier
  • Puerta, Raquel
  • Cano, Amanda
  • Orellana, Adelina
  • de Rojas, Itziar
  • Capdevila, María
  • Montrreal, Laura
  • Rosende-Roca, Maitée
  • García-González, Pablo
  • Olivé, Claudia
  • García-Gutiérrez, Fernando
  • Blázquez, Josep
  • Miguel, Andrea
  • Núñez-Llaves, Raúl
  • Pytel, Vanesa
  • Alegret, Montserrat
  • Fernández, María Victoria
  • Marquié, Marta
  • Valero, Sergi
  • Cavazos, Jose Enrique
  • Mañes, Santos
  • Boada, Mercè
  • Cabrera-Socorro, Alfredo
  • Ruiz, Agustín
Despite the central role attributed to neuroinflammation in the etiology and pathobiology of Alzheimer's disease (AD), the direct link between levels of inflammatory mediators in blood and cerebrospinal fluid (CSF) compartments, as well as their potential implications for AD diagnosis and progression, remains inconclusive. Moreover, there is debate on whether inflammation has a protective or detrimental effect on disease onset and progression. Indeed, distinct immunological mechanisms may govern protective and damaging effects at early and late stages, respectively. This study aims to (i) identify inflammatory mediators demonstrating robust correlations between peripheral and central nervous system (CNS) compartments by means of plasma and CSF analysis, respectively, and (ii) assess their potential significance in the context of AD and disease progression from mild cognitive impairment (MCI) to dementia. To achieve this, we have examined the inflammatory profile of a well-defined subcohort comprising 485 individuals from the Ace Alzheimer Center Barcelona (ACE). Employing a hierarchical clustering approach, we thoroughly evaluated the intercompartmental correlations of 63 distinct inflammation mediators, quantified in paired CSF and plasma samples, using advanced SOMAscan technology. Of the array of mediators investigated, only six mediators (CRP, IL1RAP, ILRL1, IL6RA, PDGFRB, and YKL-40) exhibited robust correlations between the central and peripheral compartments (proximity scores <400). To strengthen the validity of our findings, these identified mediators were subsequently validated in a second subcohort of individuals from ACE (n = 873). The observed plasma correlations across the entire cohort consistently have a Spearman rho value above 0.51 (n = 1,360, p < 1.77E-93). Of the high CSF-plasma correlated proteins, only soluble IL6RA (sIL6RA) displayed a statistically significant association with the conversion from MCI to dementia. This association remained robust even after applying a stringent Bonferroni correction (Cox proportional hazard ratio [HR] = 1.936 per standard deviation; p = 0.0018). This association retained its significance when accounting for various factors, including CSF amyloid (Aβ42) and Thr181-phosphorylated tau (p-tau) levels, age, sex, baseline Mini-Mental State Examination (MMSE) score, and potential sampling biases identified through principal component analysis (PCA) modeling. Furthermore, our study confirmed the association of both plasma and CSF levels of SPARC-related modular calcium-binding protein 1 (SMOC1) with amyloid and tau accumulation, indicating their role as early surrogate biomarkers for AD pathology. Despite the lack of a statistically significant correlation between SMOC1 levels in CSF and plasma, both acted as independent biomarkers of disease progression (HR > 1.3, p < 0.002). In conclusion, our study unveils that sIL6RA and SMOC1 are associated with MCI progression. The absence of correlations among inflammatory mediators between the central and peripheral compartments appears to be a common pattern, with only a few intriguing exceptions., A. Ruiz received support from the HARPONE project, Agency for Innovation and Entrepreneurship (VLAIO) grant Nº PR067/21 and Jansen; from the PREADAPT project, Joint Program for Neurodegenerative Diseases (JPND) grant Nº AC19/00097; from the ADAPTED project, EU/EFPIA Innovative Medicines Initiative Joint Undertaking grant Nº 115975; from the DESCARTES project, German Research Foundation (DFG); and from Fundación Bancaria“La Caixa”, Fundación Echevarne and Grifols S.A. (GR@ACE project). Research funding support for the analyses was granted to the Ace Alzheimer Center Barcelona (X. Morató and M. Boada) by Novo Nordisk. S. Manes received support from the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) (grant PID2020-116303RB-I00). The authors acknowledge the support of the Spanish Ministry of Science and Innovation, Proyectos de Generación de Conocimiento grant PID2021-122473OA-I00. Support was also given by Acción Estratégica en Salud, integrated into the Spanish National R +D +I Plan and financed by ISCIII Subdirección General de Evaluaci´ on and Fondo Europeo de Desarrollo Regional (FEDER“Una manera de hacer Europa") grants PI17/01474, PI19/00335, PI22/01403, and PI22/00258 and ISCIII national grant PMP22/00022, funded by the European Union (NextGenerationEU). The support of CIBERNED (ISCIII) under grants CB06/05/ 2004 and CB18/05/00010 is also acknowledged. A. Cano received support from the Instituto de Salud Carlos III (ISCIII) under the grant Sara Borrell (CD22/00125) and from Fundación ADEY (under the program“Proyectos de Investigacioón en Salud 2023”). I. de Rojas was supported by ISCIII under grant FI20/00215. P. García-Gonz´ alez was supported by the CIBERNED employment plan (CNV-304-PRF-866). S. Valero received support from the TARTAGLIA project, the program of the Spanish Ministry of Science and Innovation R&D Missions in Artificial Intelligence, the Spain Digital 2025 Agenda, and the National Artificial Intelligence Strategy, financed by the European Union through Next Generation EU funds, under grant Nº MIA.2021.M02.0005., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The role of laminins in cancer pathobiology: a comprehensive review

  • Nonnast, Elena
  • Mira, Emilia
  • Mañes, Santos
Laminins (LMs) are a family of heterotrimeric glycoproteins that form the structural foundation of basement membranes (BM). By acting as molecular bridges between cells and the extracellular matrix (ECM) through integrins and other surface receptors, they regulate key cellular signals that influence cell behavior and tissue architecture. Despite their physiological importance, our understanding of the role of LMs in cancer pathobiology remains fragmented. In this article, we review the diverse functions of LMs in promoting cancer cell proliferation, adhesion, and migration-critical steps in cancer metastasis. Beyond their direct effects on tumor cells, LMs influence stromal interactions and modulate tumor microenvironment dynamics, affecting processes such as angiogenesis, immune cell infiltration, cancer-associated fibroblast activation, and immune evasion. Understanding the complex roles of LMs in cancer biology, as well as their differential expression patterns in malignancies, could provide new diagnostic tools for predicting disease outcomes and pave the way for innovative therapeutic strategies, such as targeting LM-receptor interactions or modulating ECM dynamics to impede tumor growth and metastasis., The work was supported by the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/ https://doi.org/10.13039/501100011033 ) under grants PID2020-116303RB-I00, PID2023-147125OB-I00, EU Next Generation (EU/PRTR) CPP2021-009090, and CEX2023-001386-S (Severo Ochoa Programme); and the Asociación Española Contra el Cancer Foundation under grant PRYGN211240MA\u00D1E. Elena Nonnast is supported by a predoctoral fellowship from the Formaci\u00F3n de Personal Investigador (PRE2021-097603), from the Spanish Ministry of Science, Innovation and Universities with the support of the EU European Social Fund. SM belongs to the Spanish National Research Council (CSIC)\u2019s Cancer Hub., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A laminin α4–CD8+ T cell axis shapes the prognostic impact of macrophages and regulatory T cells in early-stage colorectal cancer

  • Nonnast, Elena
  • Fernandez-Aceñero, M. Jesús
  • Pons, Tirso
  • Sorzano, Carlos Óscar S.
  • Mira, Emilia
  • Díaz Suarez, María del Pilar
  • Mañes, Santos
The crossing of the endothelial basement membranes (BMs) is a limiting step for leukocyte diapedesis. Heterotrimeric laminins (LMs) containing α4- and α5-chains are major BM components with opposite effects on transendothelial migration. Here, we examined whether LMα4 levels influence intratumor accumulation of specific immune cells and their impact on prognosis of early-stage colorectal cancer (CRC). Using two independent patient cohorts, we found that LMα4 expression positively correlated with intratumor infiltration of CD8 T cells and macrophages, but not with regulatory T (Treg) cells. Kaplan-Meier and multivariate Cox regression analyses identified CD8 T cell density as the strongest independent prognostic factor associated with reduced tumor relapse in both cohorts. While intratumor macrophage and Treg cell densities alone were not independently associated with prognosis, their abundance modulated outcomes specifically in tumors with high CD8 T cell infiltration, with macrophage-rich tumors showing improved outcomes and Treg cell-enriched tumors exhibiting worse prognosis. Analysis of The Cancer Genome Atlas (TCGA) COAD cohort confirmed the positive correlation of LMα4 expression with both CD8 T cell and macrophage infiltration, an association that was independent of the CRC clinical stage. Our findings suggest a subtype-specific effect for LMα4 in intratumor leukocyte infiltration, and underscore the prognostic interactions among CD8 T cells, Treg cells and macrophages in early-stage colorectal cancer., The work was funded by Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033) under grants PID2020-116303RB-I00 (SM), PID2023-147125OB-I00 (SM), and CEX2023-001386-S (Severo Ochoa Programme); and the Asociación Española Contra el Cáncer Foundation under grant PRYGN211240MAÑE (SM). Elena Nonnast is supported by a predoctoral fellowship from the Formación de Personal Investigador (PRE2021-097603), from the Spanish Ministry of Science and Innovation with the support of the EU European Social Fund. TP is supported in part by the Comunidad de Madrid under grant P2022/BMD-7321/MITIC-CM. SM belongs to the Spanish National Research Council (CSIC)’s Cancer Hub; Fundación Científica Asociación Española Contra el Cáncer [PRYGN211240MAÑE]; Ministerio de Ciencia e Innovación [PID2020-116303RB-I00, PID2023-147125OB-I00,]; Ministerio de Ciencia e Innovación [PRE2021-097603]; Ministerio de Ciencia e Innovación [CEX2023-001386-S].